After surgical treatment, patients with stage IIa cervical cancer are usually required to undergo additional adjuvant chemotherapy. Cervical cancer is a common malignant tumor of female reproductive system, which can be caused by human papillomavirus infection, hormone level and other factors. According to clinical staging, patients with stage IIa are those whose tumor extends beyond the uterus but does not invade the pelvic wall or the lower third of the vagina; with or without regional lymph node metastasis and without distant metastasis. In this period, since the tumor lesions are not limited, after patients undergo surgical resection treatment, postoperative adjuvant chemotherapy is usually needed to eliminate the remaining cancer cells and improve the cure rate. Commonly used chemotherapeutic drugs such as cisplatin and paclitaxel should be applied under the guidance of doctors.